Use of HPPD inhibitors in the treatment of depression and/or withdrawal symptoms associated with addictive drugs

Details for Australian Patent Application No. 2006347397 (hide)

Owner Syngenta Limited

Inventors Travis, Kim Zachary; Posner, John

Agent Spruson & Ferguson

Pub. Number AU-A-2006347397

PCT Pub. Number WO2008/020150

Filing date 18 August 2006

Wipo publication date 21 February 2008

International Classifications

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/00 (2006.01)

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/277 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/42 (2006.01) - Oxazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4439 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/020150 Priority application(s): WO2008/020150

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006347403-Pharmaceutical formulation for the treatment of complaints

2006347391-Positively charged water-soluble prodrugs of aryland heteroarylpropionic acids with very fast skin penetration rate